Biologics Market Size, Share & Growth Analysis Report 2026–2034 The global biologics market is expanding rapidly as demand for advanced biological therapies increases across oncology, infectious diseases, immunological disorders, and other therapeutic areas. According to Straits Research, the global biologics market size was valued at USD 611.17 billion in 2025 and is projected to...

The global biologics market size was recorded at USD 478.34 billion in 2023, estimated to reach USD 525.10 billion in 2024, and projected to attain USD 1,107.30 billion by 2031, growing at a CAGR of 11.25% during the forecast period (2024–2031). The market growth is fueled by the increasing prevalence of chronic diseases, advancements in biotechnology,...

The global biologics market size was recorded at USD 478.34 billion in 2023, estimated to reach USD 525.10 billion in 2024, and projected to attain USD 1,107.30 billion by 2031, growing at a CAGR of 11.25% during the forecast period (2024–2031). The market growth is fueled by the increasing prevalence of chronic diseases, advancements in biotechnology,...

  Market Overview Polaris Market Research’s latest research report, titled Biologics Manufacturing Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth...

The global Inhalable Biologics Market is emerging as a transformative segment within the pharmaceutical and biotechnology industries, characterized by its potential to revolutionize drug delivery and patient compliance. Leveraging inhalation as a non-invasive route for administering biologics, the market is set to reshape treatment paradigms for a wide range of chronic and acute...

The global Inhalable Biologics Market is emerging as a transformative segment within the pharmaceutical and biotechnology industries, characterized by its potential to revolutionize drug delivery and patient compliance. Leveraging inhalation as a non-invasive route for administering biologics, the market is set to reshape treatment paradigms for a wide range of chronic and acute...